Neuropace Inc (NPCE)
Healthcare
Medical Devices
—
12.90 $
-6.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Neuropace Inc (NPCE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.3% of the shares are freely tradable; institutional investors hold 96.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
96.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
4.0%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
68.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
2.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
34Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Polar Capital Holdings PLC | 9.67 | 3,298,104 | +14.6 | 03/31/2026 |
| Soleus Capital Management, L.P. | 8.60 | 2,932,207 | +8.5 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 7.53 | 2,566,839 | +0.7 | 03/31/2026 |
| First Light Asset Management, LLC | 7.22 | 2,459,966 | +82.3 | 03/31/2026 |
| BlackRock Inc | 6.88 | 2,346,333 | -1.6 | 03/31/2026 |
| Orbimed Advisors, LLC | 6.15 | 2,096,527 | -12.9 | 03/31/2026 |
| Vanguard Group Inc | 4.35 | 1,482,228 | +3.2 | 12/31/2025 |
| Driehaus Capital Management LLC | 4.26 | 1,451,611 | -3.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.30 | 1,123,711 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Polar Capital Healthcare Opports Inc | 8.47 | 2,888,289 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.